1.Advances in genetic research on autism spectrum disorders.
Kaituo HUANG ; Ye ZHANG ; Rui ZHAO ; Shanshan HU
Chinese Journal of Medical Genetics 2022;39(1):103-107
Autism spectrum disorder (ASD) is a set of neurodevelopmental disorders. Patients usually exhibit certain degree of social interaction impairment in accompany with impairment in language development as well as repetitive behaviors or interests. In recent years, ASD-related variants, genes, functional pathways, and expression patterns in the brain have been discovered, along with advance in sequencing techniques. This article reviews various aspects of genetic research in association with ASD.
Autism Spectrum Disorder/genetics*
;
Cognition
;
Genetic Research
;
Humans
;
Neurodevelopmental Disorders
2.Genetics of Autism Spectrum Disorder: Current Status and Possible Clinical Applications.
Experimental Neurobiology 2015;24(4):257-272
Autism spectrum disorder (ASD) is one of the most complex behavioral disorders with a strong genetic influence. The objectives of this article are to review the current status of genetic research in ASD, and to provide information regarding the potential candidate genes, mutations, and genetic loci possibly related to pathogenesis in ASD. Investigations on monogenic causes of ASD, candidate genes among common variants, rare de novo mutations, and copy number variations are reviewed. The current possible clinical applications of the genetic knowledge and their future possibilities are highlighted.
Autistic Disorder*
;
Child
;
Autism Spectrum Disorder*
;
Genetic Loci
;
Genetic Research
;
Genetics*
3.Shanghai Autism Early Development: An Integrative Chinese ASD Cohort.
Yuan DAI ; Yuqi LIU ; Lingli ZHANG ; Tai REN ; Hui WANG ; Juehua YU ; Xin LIU ; Zilin CHEN ; Lin DENG ; Minyi TAO ; Hangyu TAN ; Chu-Chung HUANG ; Jiaying ZHANG ; Qiang LUO ; Jianfeng FENG ; Miao CAO ; Fei LI
Neuroscience Bulletin 2022;38(12):1603-1607
4.Association of CDH11 with Autism Spectrum Disorder Revealed by Matched-gene Co-expression Analysis and Mouse Behavioral Studies.
Nan WU ; Yue WANG ; Jing-Yan JIA ; Yi-Hsuan PAN ; Xiao-Bing YUAN
Neuroscience Bulletin 2022;38(1):29-46
A large number of putative risk genes for autism spectrum disorder (ASD) have been reported. The functions of most of these susceptibility genes in developing brains remain unknown, and causal relationships between their variation and autism traits have not been established. The aim of this study was to predict putative risk genes at the whole-genome level based on the analysis of gene co-expression with a group of high-confidence ASD risk genes (hcASDs). The results showed that three gene features - gene size, mRNA abundance, and guanine-cytosine content - affect the genome-wide co-expression profiles of hcASDs. To circumvent the interference of these features in gene co-expression analysis, we developed a method to determine whether a gene is significantly co-expressed with hcASDs by statistically comparing the co-expression profile of this gene with hcASDs to that of this gene with permuted gene sets of feature-matched genes. This method is referred to as "matched-gene co-expression analysis" (MGCA). With MGCA, we demonstrated the convergence in developmental expression profiles of hcASDs and improved the efficacy of risk gene prediction. The results of analysis of two recently-reported ASD candidate genes, CDH11 and CDH9, suggested the involvement of CDH11, but not CDH9, in ASD. Consistent with this prediction, behavioral studies showed that Cdh11-null mice, but not Cdh9-null mice, have multiple autism-like behavioral alterations. This study highlights the power of MGCA in revealing ASD-associated genes and the potential role of CDH11 in ASD.
Animals
;
Autism Spectrum Disorder/genetics*
;
Brain
;
Cadherins/genetics*
;
Gene Expression
;
Mice
;
Mice, Knockout
5.Clinical and genetic analysis of a child with Mental retardation autosomal dominant 51.
Yulin TANG ; Xiaojing LI ; Wenlin WU ; Zhen SHI ; Wenxiong CHEN ; Yang TIAN
Chinese Journal of Medical Genetics 2023;40(6):696-700
OBJECTIVE:
To explore the clinical characteristics and genetic basis of a child with Mental retardation autosomal dominant 51 (MRD51).
METHODS:
A child with MRD51 who was hospitalized at Guangzhou Women and Children's Medical Center on March 4, 2022 was selected as the study subject. Clinical data of the child was collected. Peripheral blood samples of the child and her parents were collected and subjected to whole exome sequencing (WES). Candidate variants were verified by Sanger sequencing and bioinformatic analysis.
RESULTS:
The child, a 5-year-and-3-month-old girl, had manifested autism spectrum disorder (ASD), mental retardation (MR), recurrent febrile convulsions and facial dysmorphism. WES revealed that she has harbored a novel heterozygous variant of c.142G>T (p.Glu48Ter) in the KMT5B gene. Sanger sequencing confirmed that neither of her parents has carried the same variant. The variant has not been recorded in the ClinVar, OMIM and HGMD, ESP, ExAC and 1000 Genomes databases. Analysis with online software including Mutation Taster, GERP++ and CADD indicated it to be pathogenic. Prediction with SWISS-MODEL online software suggested that the variant may have a significant impact on the structure of KMT5B protein. Based on the guidelines from the American College of Medical Genetics and Genomics (ACMG), the variant was predicted to be pathogenic.
CONCLUSION
The c.142G>T (p.Glu48Ter) variant of the KMT5B gene probably underlay the MRD51 in this child. Above finding has expanded the spectrum of KMT5B gene mutations and provided a reference for clinical diagnosis and genetic counseling for this family.
Humans
;
Female
;
Child, Preschool
;
Intellectual Disability/genetics*
;
Autism Spectrum Disorder/genetics*
;
Mutation
6.Autism spectrum disorder/development delay in siblings with SCN2A mutations caused by germline mosaicism.
Pingping ZHANG ; Zhijie GAO ; Jia JIA ; Qian CHEN
Chinese Journal of Medical Genetics 2021;38(11):1097-1100
OBJECTIVE:
To report on a family which has two siblings with SCN2A mutation caused by germline mosaicism suffering from autism spectrum disorder/development delay (ASD/DD).
METHODS:
Clinical data was collected for the proband and his parents. Next generation sequencing (NGS) was carried out on the proband and his parents. Suspected mutations were verified by Sanger sequencing of the proband, his parents and brother. To detect whether there is a low proportion of somatic mosaicism in the parents, a droplet digital PCR was conducted. The result of ddPCR showed that the father was germline mosaicism (0.233%).
RESULTS:
NGS has identified a de novo splicing mutation of the SCN2A gene, c.605+1G>A, in the proband and his brother. Combined with its clinical phenotype and inheritance pattern, SCN2A was judged to be the pathogenic gene. Above findings strongly suggested parental germline mosaicism.
CONCLUSION
ASD/DD in siblings with SCN2A mutations caused by germline mosaicism. Paternal mosaicism should be considered as one of the important inheritance patterns for counseling parents with a child carrying SCN2A mutation. The ddPCR can help to reveal very low proportion of germline mosaicism.
Autism Spectrum Disorder
;
Germ Cells
;
Humans
;
Male
;
Mosaicism
;
Mutation
;
NAV1.2 Voltage-Gated Sodium Channel/genetics*
;
Siblings
7.Whole exome sequencing analysis of a patient with 45,X/46,XY mosaicism and autism spectrum disorder.
Danfeng YUAN ; Jian JIAO ; Manxue ZHANG ; Sixun LI ; Zhuo WANG ; Yanping YANG ; Mingjing SITU ; Meiwen WANG ; Tingting LUO ; Yi HUANG
Chinese Journal of Medical Genetics 2022;39(3):297-300
OBJECTIVE:
To carry out genetic testing for a patient with 45,X/46,XY mosaicism and autism spectrum disorder (ASD).
METHODS:
Peripheral blood samples of the patient and his parents were collected for the extraction of genomic DNA. Trio-based whole exome sequencing and Sanger sequencing were carried out thereafter.
RESULTS:
The proband and his father were found to harbor a heterozygous c.4781G>A (p.Arg1594Gln) variant of the CACNA1I gene. In addition, the proband was also found to harbor a de novo c.268C>T (p.Arg90Trp) missense variant of the MTRR gene. Based on guidelines of the American College of Medical Genetics and Genomics (ACMG), the c.4781G>A (p.Arg1594Gln) variant of the CACNA1I gene was predicted to be pathogenic (PVS1, PM1, PM2, PP3), while the c.268C>T (p.Arg90Trp) variant of the MTRR gene was predicted to be of uncertain significance.
CONCLUSION
Variants of the CACNA1I and MTRR genes, together with the chromosomal mosaicism, may have predisposed to the susceptibility to the ASD in this patient.
Autism Spectrum Disorder/genetics*
;
Genomics
;
Heterozygote
;
Humans
;
Mosaicism
;
Whole Exome Sequencing
8.New Therapeutic Options for Autism Spectrum Disorder: Experimental Evidences.
Experimental Neurobiology 2015;24(4):301-311
Autism spectrum disorder (ASD) is characterized by impairment in two behavioral domains: social interaction/communication together with the presence of stereotyped behaviors and restricted interests. The heterogeneity in the phenotype among patients and the complex etiology of the disorder have long impeded the advancement of the development of successful pharmacotherapies. However, in the recent years, the integration of findings of multiple levels of research, from human genetics to mouse models, have made considerable progress towards the understanding of ASD pathophysiology, allowing the development of more effective targeted drug therapies. The present review discusses the current state of pharmacological research in ASD based on the emerging common pathophysiology signature.
Animals
;
Autistic Disorder*
;
Child
;
Autism Spectrum Disorder*
;
Drug Therapy
;
Genetics, Medical
;
Humans
;
Mice
;
Phenotype
;
Population Characteristics
;
Social Behavior
;
Stereotyped Behavior
9.Sleep Problems in Autism Spectrum Disorder.
Young Hui YANG ; Ji Hoon KIM ; Jin Seong LEE
Sleep Medicine and Psychophysiology 2013;20(2):53-58
Autism Spectrum Disorder (ASD) is characterized by persistent deficits in social communication and restricted, repetitive patterns of behavior and interest. Sleep problems are not uncommon in children with autism spectrum disorders. Symptoms of insomnia are the most frequent sleep problems in individuals with ASD. Sleep problems can cause significant difficulties in the daily life of children with ASD and their families. Genetic factor, deregulations of melatonin synthesis, extraneous environmental stimuli and psychiatric and medical conditions may cause sleep problems. The first line treatment of sleep problems in ASD includes managements for potential contributing factors and parent education about sleep hygiene care for child and behavioral therapy. Supplementation with melatonin may be effective before considering other medications, such as risperidone, clonidine, and mirtazapine.
Autistic Disorder*
;
Child
;
Autism Spectrum Disorder*
;
Clonidine
;
Education
;
Genetics
;
Humans
;
Hygiene
;
Melatonin
;
Parents
;
Risperidone
;
Sleep Initiation and Maintenance Disorders
10.Research advances in candidate genes for autism spectrum disorder.
Chinese Journal of Contemporary Pediatrics 2016;18(3):282-287
Autism spectrum disorder (ASD) is a kind of neurodevelopmental multigenic disorder. More than one hundred of candidate genes for ASD have been reported. The candidate gene research for ASD involves in chromosome loci and screening of candidate genes and epigenetic abnormalities for candidate genes. The reported genes encode neural adhesion molecules, ion channels, scaffold proteins, protein kinases, receptor protein and carrier protein, signaling modulate molecules and circadian relevant proteins. The research of mutation screening and expression regulation of candidate genes can help to elucidate genetic mechanisms for ASD, and may provide new approaches for the diagnosis and treatment of this disorder. This article reviews the research advance in candidate genes for ASD.
Autism Spectrum Disorder
;
genetics
;
Gene Dosage
;
Genetic Predisposition to Disease
;
Humans
;
Ion Channels
;
genetics
;
Nerve Tissue Proteins
;
genetics
;
Signal Transduction
;
genetics